New report on Erectile Dysfunction Drugs is also termed as impotence and it is characterized by incapability to build up or sustain a penile erection during sexual intercourse. An Erection of penis involves hydraulic effect resulting from entry and retention of blood into spongy bodies within penis. Sexual arousal is responsible for initiation of this process which is signalized by impulse mechanism from brain to penile nerves. The causes of erectile dysfunction involve side effects of drugs, Cavernosal disorders, Neurogenic disorders, Aging, Psychological causes, Multiple sclerosis and Diabetes, and Lifestyle modifications. Pin-point analysis of global erectile dysfunction drugs market focuses on various aspects of market such as, market trends, market drivers, restrains and opportunities. Competitive landscape section focuses on key leaders within global erectile dysfunction drugs market and their major growth strategies. Deep-dive assessment of segments identifies the potential segment which would act as guide to strategist. Global Erectile Dysfunction Drugs Market by Geography Geographically, global erectile dysfunction drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America dominates the global erectile dysfunction drugs market and it is expected to show the same results during forecast period due to the presence of Cialis and Viagra in U.S. market. Patent expiration of these brands outside the U.S. markets, would increase the influx of generics with cheaper prices.